Cystatin C prevents degeneration of rat nigral dopaminergic neurons: In vitro and in vivo studies

Neurobiology of Disease

Volumn 18, Issue 1, 2005, Pages 152-165

  Xu, Lei ^a,b   Sheng, Jiansong ^a,b   Tang, Zhongshu ^a   Wu, Xuefei ^a   Yu, Yi ^a   Guo, Hong ^a   Shen, Yan ^a   Zhou, Changfu ^b,c   Paraoan, Luminita ^d   Zhou, Jiawei ^a,b,e  

^a Shanghi Institutes Biol Sci C   (China)

^b UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

^c Shanghai Jiao Tong University Affiliated Sixth People s Hospital   (China)

^d UNIVERSITY OF LIVERPOOL   (United Kingdom)

^e INSTITUTE OF GEOLOGY AND GEOPHYSICS   (China)

Author keywords

Cathepsin; Cell culture; Cystatin C; Dopaminergic; Parkinson's disease

Indexed keywords

CYSTATIN C; CYSTEINE PROTEINASE INHIBITOR; MESSENGER RNA; NEUROTOXIN; OXIDOPAMINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINERGIC NERVE CELL; DRUG BLOOD LEVEL; FEMALE; FLUORESCENCE; IMMUNOHISTOCHEMISTRY; NERVE CELL DEGENERATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RAT;

ANIMALS; ASTROCYTES; CELL SURVIVAL; CELLS, CULTURED; CYSTATINS; CYSTEINE PROTEINASE INHIBITORS; DISEASE MODELS, ANIMAL; DOPAMINE; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; MICROGLIA; NERVE DEGENERATION; NEURONS; NEUROPROTECTIVE AGENTS; OXIDOPAMINE; PARKINSONIAN DISORDERS; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; SUBSTANTIA NIGRA; TIME FACTORS; UP-REGULATION;

EID: 19944426120     PISSN: 09699961     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nbd.2004.08.012     Document Type: Article

References (56)

1. M. Abrahamson, A.J. Barrett, G. Salvesen, and A. Grubb Isolation of six cysteine proteinase inhibitors from human urine. Their physicochemical and enzyme kinetic properties and concentrations in biological fluids J. Biol. Chem. 261 1986 11282 11289
2. M. Abrahamson, I. Olafsson, A. Palsdottir, M. Ulvssback, A. Lundwall, O. Jensson, and A. Grubb Structure and expression of the human cystatin C gene Biochem. J. 268 1990 287 294
3. T. Akopyan Protein inhibitors of proteinases from brain Neurochem. Res. 16 1991 513 517
4. A. Anastasi, M.A. Brown, A.A. Kembhavi, M.J. Nicklin, C.A. Sayers, D.C. Sunter, and A.J. Barrett Cystatin, a protein inhibitor of cysteine proteinases. Improved purification from egg white, characterization, and detection in chicken serum Biochem. J. 211 1983 129 138
5. E. Aronica, E.A. van Vliet, E. Hendriksen, D. Troost, F.H. Lopes da Silva, and J.A. Gorter Cystatin C, a cysteine protease inhibitor, is persistently up-regulated in neurons and glia in a rat model for mesial temporal lobe epilepsy Eur. J. Neurosci. 14 2001 1485 1491
6. A.J. Barrett, and H. Kirschke Cathepsin B, cathepsin H, and cathepsin L Methods Enzymol. 80 Pt C 1981 535 561
7. A.J. Barrett, M.E. Davies, and A. Grubb The place of human gamma-trace (cystatin C) amongst the cysteine proteinase inhibitors Biochem. Biophys. Res. Commun. 120 1984 631 636
8. R. Betarbet, T. Sherer, and J.T. Greenamyre Animal models of Parkinson's disease BioEssays 24 2002 308 318
9. P.M. Carvey, L.R. Ptak, S.T. Nath, D.K. Sierens, E.J. Mufson, C.G. Goetz, and H.L. Klawans Striatal extracts from patients with Parkinson's disease promote dopamine neurons growth in mesencephalic cultures Exp. Neurol. 120 1993 149 152
10. L.L. Crews, and D.J. Wigston The dependence of motorneurons on their target muscle during postnatal development of the mouse J. Neurosci. 10 1990 1643 1653
11. S.J. Crocker, P.D. Smith, V. Jackson-Lewis, W.R. Lamba, S.P. Hayley, E. Grimm, S.M. Callaghan, R.S. Slack, E. Melloni, S. Przedborski, G.S. Robertson, H. Anisman, Z. Merali, and D.S. Park Inhibition of calpains prevents neuronal and behavioral deficits in an MPTP mouse model of Parkinson's disease J. Neurosci. 23 2003 4081 4091
12. T.M. Dawson, and V.L. Dawson Molecular pathways of neurodegeneration in Parkinson's disease Science 302 2003 819 822
13. K.J. Elliott, J.M. Jones, A.I. Sacaan, G.K. Lioyd, and J. Corey-Naeve 6-Hydroxydopamine lesion of rat nigrostriatal dopaminergic neurons differentially affects nicotinic acetylcholine receptor subunit mRNA expression J. Mol. Neurosci. 10 1998 251 260
14. B. Ferger, S. Rose, A. Jenner, B. Halliwell, and P. Jenner 6-Hydroxydopamine increases hydroxyl free radical production and DNA damage in rat striatum NeuroReport 12 2001 1155 1159
15. H. Hida, C.G. Jung, C.Z. Wu, H.J. Kim, Y. Kodama, T. Masuda, and H. Nishino Pleiotrophin exhibits a trophic effect on survival of dopaminergic neurons in vitro Eur. J. Neurosci. 17 2003 2127 2134
16. H. Ishimaru, K. Ishikawa, Y. Ohe, A. Takahashi, and Y. Maruyama Cystatin C and apolipoprotein E immunoreactivities in CA1 neurons in ischemic gerbil hippocampus Brain Res. 709 1996 155 162
17. C.M. Kearns, W.A. Cass, K. Smoot, R. Kryscio, and D.M. Gash GDNF protection against 6-OHDA: time dependence and requirement for protein synthesis J. Neurosci. 17 1997 7111 7118
18. P.J. Kingham, and J.M. Pocock Microglial secreted cathepsin B induces neuronal apoptosis J. Neurochem. 76 2001 1475 1484
19. K.S. Lee, S. Frank, P. Vanderklish, A. Arai, and G. Lynch Inhibition of proteolysis protects hippocampal neurons from ischemia Proc. Natl. Acad. Sci. U. S. A. 88 1991 7233 7237
20. D.C. Lee, D.E. Palm, I.M. Jackson, T. Womble, and C. Wight Cystatin C expression in apoptotic PC12 cells following 6-hydroxydopamine toxicity Abstr. - Soc. Neurosci. 2002 194.112
21. E. Levy, M. Sastre, A. Kumar, G. Gallo, P. Piccardo, B. Ghetti, and F. Tagliavini Codeposition of cystatin C with amyloid-beta protein in the brain of Alzheimer disease patients J. Neuropathol. Exp. Neurol. 60 2001 94 104
22. H. Lofberg, A.O. Grubb, T. Sveger, and J.E. Olsson The cerebrospinal fluid and plasma concentrations of gamma-trace and beta2-microglobulin at various ages and in neurological disorders J. Neurol. 223 1980 159 170
23. H. Lofberg, K.E. Nilsson, L.G. Stromblad, A. Lasson, and S.O. Olsson Demonstration of gamma-trace in normal endocrine cells of the adrenal medulla and in phaeochromocytoma. An immunohistochemical study in monkey, dog and man Acta Endocrinol. (Copenh) 100 1982 595 598
24. H. Lofberg, A. Grubb, L. Davidsson, B. Kjellander, L.G. Stromblad, S. Tibblin, and S.O. Olsson Occurrence of gamma-trace in the calcitonin-producing C-cells of simian thyroid gland and human medullary thyroid carcinoma Acta Endocrinol. (Copenh) 104 1983 69 76
25. J. Lotharius, L.L. Dugan, and K.L. O'Malley Distinct mechanisms underlie neurotoxin-mediated cell death in cultured dopaminergic neurons J. Neurosci. 19 1999 1284 1293
26. G. Lynch, and M. Baudry The biochemistry of memory: a new and specific hypothesis Science 224 1984 1057 1063
27. D. Mantle, G. Falkous, S. Ishiura, R.H. Perry, and E.K. Perry Comparison of cathepsin protease activities in brain tissue from normal cases and cases with Alzheimer's disease, Lewy body dementia, Parkinson's disease and Huntington's disease J. Neurol. Sci. 131 1995 65 70
28. M. Mogi, A. Togari, K.-I. Tanaka, N. Ogawa, H. Ichinose, and T. Nagatsu Increase in level of tumor necrosis factor-α in 6-hydroxydopamine-lesioned striatum in rats is suppressed by immunosuppressant FK506 Neurosci. Lett. 289 2000 165 168
29. C. Nishio, K. Yoshida, K. Nishiyama, H. Hatanaka, and M. Yamada Involvement of cystatin C in oxidative stress-induced apoptosis of cultured rat CNS neurons Brain Res. 873 2000 252 262
30. T. Nitatori, N. Sato, S. Waguri, Y. Karasawa, H. Araki, K. Shibanai, E. Kominami, and Y. Uchiyama Delayed neuronal death in the CA1 pyramidal cell layer of the gerbil hippocampus following transient ischemia is apoptosis J. Neurosci. 15 1995 1001 1011
31. S. Numan, and K.B. Seroogy Increased expression of trkB mRNA in rat caudate-putamen following 6-OHDA lesions of the nigrostriatal pathway Eur. J. Neurosci. 9 1997 489 495
32. Y. Ohe, K. Ishikawa, Z. Itoh, and K. Tatemoto Cultured leptomeningeal cells secrete cerebrospinal fluid proteins J. Neurochem. 67 1996 964 971
33. D.E. Palm, N.W. Knuckey, M.J. Primiano, A.G. Spangenberger, and C.E. Johanson Cystatin C, a protease inhibitor, in degenerating rat hippocampal neurons following transient forebrain ischemia Brain Res. 691 1995 1 8
34. L. Paraoan, M.R.H. White, D.G. Spiller, I.B. Grierson, and E.H. Maden Precursor cystatin C in cultured retinal pigment epithelium cells: evidence for processing through the secretory pathway Mol. Membr. Biol. 18 2001 229 236
35. G. Paxinos, and C. Watson The Rat Brain in Stereotaxic Coordinates 1986 Academic Sydney, Australia
36. A. Rami, and J. Krieglstein Protective effects of calpain inhibitors against neuronal damage caused by cytotoxic hypoxia in vitro and ischemia in vivo Brain Res. 609 1993 67 70
37. S.K. Ray, and N.L. Banik Calpain and its involvement in the pathophysiology of CNS injuries and diseases: therapeutic potential of calpain inhibitors for prevention of neurodegeneration Curr. Drug Target CNS Neurol. Disord. 2 2003 173 189
38. J. Romero, F. Berrendero, A. Perez-Rosado, J. Manzanares, A. Rojo, J.J. Fernandez-Ruiz, J.G. de Yebenes, and J.A. Ramos Unilateral 6-hydroxydopamine lesions of nigrostriatal dopaminergic neurons increased CB1 receptor mRNA levels in the caudate-putamen Life Sci. 2000 2000 485 494
39. C. Rosenblad, M. Gronborg, C. Hansen, N. Blom, M. Meyer, J. Johansen, L. Dago, D. Kirik, U.A. Patel, C. Lundberg, D. Trono, A. Bjorklund, and T.E. Johansen In vivo protection of nigral dopamine neurons by lentiviral gene transfer of the novel GDNF-family member neublastin/artemin Mol. Cell. Neurosci. 15 2000 199 214
40. R.E. Ryan, B.F. Sloane, M. Sameni, and P.L. Wood Microglial cathepsin B: an immunological examination of cellular and secreted species J. Neurochem. 65 1995 1035 1045
41. J. Sambrock, E.F. Fritsch, and T. Maniatis Molecular Cloning: A Laboratory Manual 1989 Cold Spring Harbor Laboratory Cold Spring Harbor, NY
42. H. Sauer, and W.H. Oertel Progressive degeneration of nigrostriatal dopamine neurons following intrastriatal terminal lesions with 6-hydroxydopamine: a combined retrograde tracing and immunocytochemical study in the rat Neuroscience 59 1994 401 415
43. Y. Shen, Y. Yu, Z. Tang, H. Guo, F.-S.X. Yu, and J. Zhou Identification and comparative analysis of differentially expressed proteins in rat striatum following 6-OHDA lesions of nigrostriatal pathway: up-regulation of amyloid precursor like-protein 2 expression Eur. J. Neurosci. 16 2002 896 906
44. A. Sickmann, W. Dormeyer, S. Wortelkamp, D. Woltalla, W. Kuhn, and H.E. Meyer Identification of proteins from human cerebrospinal fluid, separated by 2-dimensional polyacrylamide gel electrophoresis Electrophoresis 21 2000 2127 2128
45. G. Sierra-Paredes, J.M. Cornes, and G. Sierra-Marcuno Calpain inhibitor I retards seizure offset in the hippocampus of freely moving rats Neurosci. Lett. 263 1999 165 168
46. Q. Sun Growth stimulation of 3T3 fibroblasts by cystatin Exp. Cell Res. 180 1989 150 160
47. U. Ungerstedt, and G.W. Arbuthnott Quantitative recording of rotational behaviour in rats after 6-hydroxydopamine lesions of the nigrostriatal dopamine system Brain Res. 24 1970 485 493
48. L. Xu, Y. Shen, Z.-S. Tang, Y. Yu, and J. Zhou Striatal extracts promote the survival and phenotype expression of fetal dopaminergic neurons in vitro Abstr. - Soc. Neurosci. 26 2000 1363
49. T. Yamashima Implication of cysteine proteases calpain, cathepsin and caspase in ischemic neuronal death of primates Prog. Neurobiol. 62 2000 273 295
50. T. Yamashima, Y. Kohda, K. Tsuchiya, T. Ueno, J. Yamashita, T. Yoshioka, and E. Kominami Inhibition of ischemic hippocampal neuronal death in primates with cathepsin B inhibitor CA-074: a novel strategy for neuroprotection based on 'calpain-cathepsin hypothesis' Eur. J. Neurosci. 10 1998 1723 1733
51. P. Yan, N. Liu, G.-M. Kim, J. Xu, J. Xu, Q. Li, C.Y. Hsu, and X.M. Xu Expression of the type 1 and type 2 receptors for tumor necrosis factor after traumatic spinal cord injury in adult rats Exp. Neurol. 183 2003 286 297
52. G.X. Ying, C. Huang, Z.H. Jiang, N.H. Jing, and C.F. Zhou Up-regulation of cystatin C expression in the murine hippocampus following perforant path transections Neuroscience 112 2002 289 298
53. J. Zhou, H.F. Bradford, and G.M. Stern The response of human and rat fetal ventral mesencephalon in culture to the brain-derived neurotrophic factor treatment Brain Res. 656 1994 147 156
54. J. Zhou, B. Pliego-Rivero, H.F. Bradford, and G.M. Stern The BDNF content of postnatal and adult rat brain: the effects of 6-hydroxydopamine lesions Dev. Brain Res. 97 1996 297 303
55. J. Zhou, Y. Yu, Z.-S. Tang, and L. Xu Differential expression of mRNAs of GDNF family in the striatum following 6-OHDA-induced lesion NeuroReport 11 2000 3289 3293
56. Y.S. Zhu, S.B. Jones, R.E. Burke, S.O. Franklin, and C.E. Inturrisi Quantitation of the levels of tyrosine hydroxylase and preproenkephalin mRNAs in nigrostriatal sites after 6-hydroxydopamine lesions Life Sci. 52 1993 1577 1584